09 March 2022: Clinical Research
Circulating Cell-Free Mitochondrial DNA: A Potential Blood-Based Biomarker for Sarcopenia in Patients Undergoing Maintenance Hemodialysis
Zhen Fan 1ABCEG* , Yi Guo 2BCD* , Xiao-yi Zhong 3CF*DOI: 10.12659/MSM.934679
Med Sci Monit 2022; 28:e934679
Figure 3 (A, B) Mitochondria appear to be impaired more severely in patients with sarcopenia. Flow cytometry analysis showing the loss of ΔΨm in PBMCs from SP (n=20) and NSP (n=20) groups. * p<0.05 compared to NSP.